
|Articles|January 13, 2020
Charles River and Takeda Announce Collaboration
Advertisement
Charles River has announced a multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited. Together they will launch multiple integrated programs across Takeda’s four core therapeutic areas with the ultimate goal of delivering preclinical candidates that Takeda can advance into clinical development.
For more information on this collaboration, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
4
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
5




